Clinical Trials Directory

Trials / Unknown

UnknownNCT01427686

Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates

Effect of Dobutamine as Compared to Dopamine on Cerebral Oxygenation, Mean Arterial Pressure and Cerebral Hemodynamics in Term and Preterm Neonates With Arterial Hypotension

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
44 Weeks
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the effects of Dobutamine as compared to Dopamine in term and preterm neonates with arterial hypotension on cerebral and renal oxygenation, fractional tissue oxygen extraction, mean arterial blood pressure and cardiac output. The investigators hypothesize that Dopamine has a stronger effect on blood pressure than Dobutamine but Dobutamine has a stronger effect on cerebral oxygenation and cardiac output than Dopamine.

Conditions

Interventions

TypeNameDescription
DRUGDobutamineStart Dobutamine with 5µg/kg/min. Increase as needed until mean arterial pressure is in normal range (defined by responsible neonatologist, usually between gestational age in weeks and 10mmHg above this threshold) or until a maximum dose of 15µg/kg/min is reached. Only in the latter case switch to Dopamine.
DRUGDopamineStart Dopamine with 5µg/kg/min. Increase as needed until mean arterial pressure is in normal range (defined by responsible neonatologist, usually between gestational age in weeks and 10mmHg above this threshold) or until a maximum dose of 15µg/kg/min is reached. Only in the latter case switch to Dobutamine.

Timeline

Start date
2011-06-01
Primary completion
2015-02-01
Completion
2016-12-01
First posted
2011-09-01
Last updated
2016-04-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01427686. Inclusion in this directory is not an endorsement.